Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Diastolic stress test echocardiography in patients with suspected heart failure with preserved ejection fraction: a pilot study.

Belyavskiy E, Morris DA, Url-Michitsch M, Verheyen N, Meinitzer A, Radhakrishnan AK, Kropf M, Frydas A, Ovchinnikov AG, Schmidt A, Tadic M, Genger M, Lindhorst R, Bobenko A, Tschöpe C, Edelmann F, Pieske-Kraigher E, Pieske B.

ESC Heart Fail. 2019 Feb;6(1):146-153. doi: 10.1002/ehf2.12375. Epub 2018 Nov 19.

2.

Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease.

Jud P, Hafner F, Verheyen N, Meinitzer A, Gary T, Brodmann M, Seinost G, Hackl G.

Sci Rep. 2018 Sep 21;8(1):14197. doi: 10.1038/s41598-018-32607-8.

3.

Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper.

Pilz S, März W, Cashman KD, Kiely ME, Whiting SJ, Holick MF, Grant WB, Pludowski P, Hiligsmann M, Trummer C, Schwetz V, Lerchbaum E, Pandis M, Tomaschitz A, Grübler MR, Gaksch M, Verheyen N, Hollis BW, Rejnmark L, Karras SN, Hahn A, Bischoff-Ferrari HA, Reichrath J, Jorde R, Elmadfa I, Vieth R, Scragg R, Calvo MS, van Schoor NM, Bouillon R, Lips P, Itkonen ST, Martineau AR, Lamberg-Allardt C, Zittermann A.

Front Endocrinol (Lausanne). 2018 Jul 17;9:373. doi: 10.3389/fendo.2018.00373. eCollection 2018. Review.

4.

Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot Trial.

Tripolt NJ, Stekovic S, Aberer F, Url J, Pferschy PN, Schröder S, Verheyen N, Schmidt A, Kolesnik E, Narath SH, Riedl R, Obermayer-Pietsch B, Pieber TR, Madeo F, Sourij H.

Adv Ther. 2018 Aug;35(8):1265-1283. doi: 10.1007/s12325-018-0746-5. Epub 2018 Jul 25.

5.

Age-dependent effects of homocysteine and dimethylarginines on cardiovascular mortality in claudicant patients with lower extremity arterial disease.

Jud P, Hafner F, Verheyen N, Gary T, Meinitzer A, Brodmann M, Seinost G, Hackl G.

Heart Vessels. 2018 Dec;33(12):1453-1462. doi: 10.1007/s00380-018-1210-9. Epub 2018 Jun 26.

6.

Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data.

Pilz S, Trummer C, Verheyen N, Schwetz V, Pandis M, Aberer F, Grübler MR, Meinitzer A, Bachmann A, Voelkl J, Alesutan I, Catena C, Sechi LA, März W, Obermayer-Pietsch B, Tomaschitz A.

Horm Metab Res. 2018 May;50(5):375-382. doi: 10.1055/a-0604-3249. Epub 2018 May 3.

PMID:
29723896
7.

The Bone-Cardiovascular Axis: Mechanisms and Clinical Relevance.

Verheyen N, Grübler MR, Catena C, Fahrleitner-Pammer A, van Ballegooijen AJ.

Int J Endocrinol. 2018 Feb 21;2018:9689106. doi: 10.1155/2018/9689106. eCollection 2018. No abstract available.

8.

Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB.

Voelkl J, Tuffaha R, Luong TTD, Zickler D, Masyout J, Feger M, Verheyen N, Blaschke F, Kuro-O M, Tomaschitz A, Pilz S, Pasch A, Eckardt KU, Scherberich JE, Lang F, Pieske B, Alesutan I.

J Am Soc Nephrol. 2018 Jun;29(6):1636-1648. doi: 10.1681/ASN.2017050492. Epub 2018 Apr 13.

PMID:
29654213
9.

Vitamin D supplementation and lipoprotein metabolism: A randomized controlled trial.

Schwetz V, Scharnagl H, Trummer C, Stojakovic T, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, Aberer F, Lerchbaum E, Obermayer-Pietsch B, Pieber TR, März W, Tomaschitz A, Pilz S.

J Clin Lipidol. 2018 May - Jun;12(3):588-596.e4. doi: 10.1016/j.jacl.2018.03.079. Epub 2018 Mar 15.

PMID:
29653812
10.

Thermic sealing in femoral catheterisation: First experience with the Secure Device.

Sacherer M, Kolesnik E, von Lewinski F, Verheyen N, Brandner K, Wallner M, Eaton DM, Luha O, Zweiker R, von Lewinski D.

Cardiol J. 2018 Apr 3. doi: 10.5603/CJ.a2018.0035. [Epub ahead of print]

11.

Effects of vitamin D supplementation on FGF23: a randomized-controlled trial.

Trummer C, Schwetz V, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, März W, Aberer F, Steinkellner J, Friedl C, Brandenburg V, Voelkl J, Alesutan I, Obermayer-Pietsch B, Pieber TR, Tomaschitz A, Pilz S.

Eur J Nutr. 2018 Mar 30. doi: 10.1007/s00394-018-1672-7. [Epub ahead of print]

PMID:
29602956
12.

Vitamin D: Current Guidelines and Future Outlook.

Pilz S, Trummer C, Pandis M, Schwetz V, Aberer F, Grübler M, Verheyen N, Tomaschitz A, März W.

Anticancer Res. 2018 Feb;38(2):1145-1151. Review.

PMID:
29374751
13.

Multiple Chronic Gouty Tophi.

Jud P, Verheyen N, Fruhwald F.

Dtsch Arztebl Int. 2018 Jan 19;115(3):30. doi: 10.3238/arztebl.2018.0030. No abstract available.

14.

Lancisi sign in a 69-year-old man with severe tricuspid regurgitation.

Jud P, Verheyen N.

CMAJ. 2018 Jan 8;190(1):E17. doi: 10.1503/cmaj.171297. No abstract available.

15.

Unfolding Cardiac Amyloidosis - From Pathophysiology to Cure.

Ablasser K, Verheyen N, Glantschnig T, Agnetti G, Rainer PP.

Curr Med Chem. 2018 Jan 4. doi: 10.2174/0929867325666180104153338. [Epub ahead of print]

PMID:
29303069
16.

Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis.

Catena C, Colussi G, Brosolo G, Verheyen N, Novello M, Bertin N, Cavarape A, Sechi LA.

Kidney Blood Press Res. 2017;42(5):774-783. doi: 10.1159/000484299. Epub 2017 Nov 21.

17.

The Synergistic Interplay between Vitamins D and K for Bone and Cardiovascular Health: A Narrative Review.

van Ballegooijen AJ, Pilz S, Tomaschitz A, Grübler MR, Verheyen N.

Int J Endocrinol. 2017;2017:7454376. doi: 10.1155/2017/7454376. Epub 2017 Sep 12. Review.

18.

Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.

Hernandez-Morales I, Geluykens P, Clynhens M, Strijbos R, Goethals O, Megens S, Verheyen N, Last S, McGowan D, Coesemans E, De Boeck B, Stoops B, Devogelaere B, Pauwels F, Vandyck K, Berke JM, Raboisson P, Simmen K, Lory P, Van Loock M.

Antiviral Res. 2017 Nov;147:149-158. doi: 10.1016/j.antiviral.2017.10.011. Epub 2017 Oct 14.

PMID:
29037976
19.

Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trial.

Verheyen N, Grübler MR, Meinitzer A, Trummer C, Schwetz V, Amrein K, Dimai HP, März W, Catena C, von Lewinski D, Voelkl J, Alesutan I, Fahrleitner-Pammer A, Brussee H, Pilz S, Tomaschitz A.

Bone. 2017 Dec;105:212-217. doi: 10.1016/j.bone.2017.08.030. Epub 2017 Sep 14.

PMID:
28918310
20.

Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial.

Wetzel J, Pilz S, Grübler MR, Fahrleitner-Pammer A, Dimai HP, von Lewinski D, Kolesnik E, Perl S, Trummer C, Schwetz V, Meinitzer A, Belyavskiy E, Völkl J, Catena C, Brandenburg V, März W, Pieske B, Brussee H, Tomaschitz A, Verheyen ND.

J Clin Hypertens (Greenwich). 2017 Nov;19(11):1173-1180. doi: 10.1111/jch.13064. Epub 2017 Aug 20.

21.

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor.

Roymans D, Alnajjar SS, Battles MB, Sitthicharoenchai P, Furmanova-Hollenstein P, Rigaux P, Berg JVD, Kwanten L, Ginderen MV, Verheyen N, Vranckx L, Jaensch S, Arnoult E, Voorzaat R, Gallup JM, Larios-Mora A, Crabbe M, Huntjens D, Raboisson P, Langedijk JP, Ackermann MR, McLellan JS, Vendeville S, Koul A.

Nat Commun. 2017 Aug 1;8(1):167. doi: 10.1038/s41467-017-00170-x.

22.

Effects of Vitamin D Supplementation on IGF-1 and Calcitriol: A Randomized-Controlled Trial.

Trummer C, Schwetz V, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, März W, Aberer F, Lang A, Friedl C, Tomaschitz A, Obermayer-Pietsch B, Pieber TR, Pilz S, Treiber G.

Nutrients. 2017 Jun 17;9(6). pii: E623. doi: 10.3390/nu9060623.

23.

Vitamin-D concentrations, cardiovascular risk and events - a review of epidemiological evidence.

Grübler MR, März W, Pilz S, Grammer TB, Trummer C, Müllner C, Schwetz V, Pandis M, Verheyen N, Tomaschitz A, Fiordelisi A, Laudisio D, Cipolletta E, Iaccarino G.

Rev Endocr Metab Disord. 2017 Jun;18(2):259-272. doi: 10.1007/s11154-017-9417-0. Review.

PMID:
28451877
24.

Effects of Vitamin D Supplementation on Bone Turnover Markers: A Randomized Controlled Trial.

Schwetz V, Trummer C, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, März W, Aberer F, Lang A, Treiber G, Friedl C, Obermayer-Pietsch B, Pieber TR, Tomaschitz A, Pilz S.

Nutrients. 2017 Apr 27;9(5). pii: E432. doi: 10.3390/nu9050432.

25.

Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial.

Verheyen N, Meinitzer A, Grübler MR, Ablasser K, Kolesnik E, Fahrleitner-Pammer A, Belyavskiy E, Trummer C, Schwetz V, Pieske-Kraigher E, Voelkl J, Alesutan I, Catena C, Sechi LA, Brussee H, Lewinski DV, März W, Pieske B, Pilz S, Tomaschitz A.

Clin Chem Lab Med. 2017 Jun 27;55(7):1034-1042. doi: 10.1515/cclm-2016-1159.

PMID:
28432842
26.

Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.

Verheyen N, Fahrleitner-Pammer A, Belyavskiy E, Gruebler MR, Dimai HP, Amrein K, Ablasser K, Martensen J, Catena C, Pieske-Kraigher E, Colantonio C, Voelkl J, Lang F, Alesutan I, Meinitzer A, März W, Brussee H, Pieske B, Pilz S, Tomaschitz A.

PLoS One. 2017 Apr 13;12(4):e0173799. doi: 10.1371/journal.pone.0173799. eCollection 2017.

27.

Effects of Vitamin D3 on asymmetric- and symmetric dimethylarginine in arterial hypertension.

Grübler MR, Gaksch M, Kienreich K, Verheyen ND, Schmid J, Müllner C, Richtig G, Scharnagl H, Trummer C, Schwetz V, Meinitzer A, Pieske B, März W, Tomaschitz A, Pilz S.

J Steroid Biochem Mol Biol. 2018 Jan;175:157-163. doi: 10.1016/j.jsbmb.2016.12.014. Epub 2016 Dec 24.

PMID:
28027911
28.

Beneficial Effects of UV-Radiation: Vitamin D and beyond.

Trummer C, Pandis M, Verheyen N, Grübler MR, Gaksch M, Obermayer-Pietsch B, Tomaschitz A, Pieber TR, Pilz S, Schwetz V.

Int J Environ Res Public Health. 2016 Oct 19;13(10). pii: E1028. Review.

29.

Moderate Alcohol Consumption Is Associated With Left Ventricular Diastolic Dysfunction in Nonalcoholic Hypertensive Patients.

Catena C, Colussi G, Verheyen ND, Novello M, Fagotto V, Soardo G, Sechi LA.

Hypertension. 2016 Nov;68(5):1208-1216. Epub 2016 Sep 26.

PMID:
27672023
30.

Letter by Verheyen et al Regarding Article, "Pacemaker Malfunction Attributed to Multidetector Cardiac Computed Tomography".

Verheyen N, Scherr D, Manninger M.

Circulation. 2016 Jul 19;134(3):e13-4. doi: 10.1161/CIRCULATIONAHA.116.021792. No abstract available.

PMID:
27436884
31.

Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial.

Verheyen N, Fahrleitner-Pammer A, Pieske B, Meinitzer A, Belyavskiy E, Wetzel J, Gaksch M, Grübler MR, Catena C, Sechi LA, Van Ballegooijen AJ, Brandenburg VM, Scharnagl H, Perl S, Brussee H, März W, Pilz S, Tomaschitz A.

J Hypertens. 2016 Sep;34(9):1778-86. doi: 10.1097/HJH.0000000000001004.

PMID:
27379537
32.

Effects of vitamin D supplementation on glycated haemoglobin and fasting glucose levels in hypertensive patients: a randomized controlled trial.

Grübler MR, Gaksch M, Kienreich K, Verheyen N, Schmid J, Ó Hartaigh B, Richtig G, Scharnagl H, Meinitzer A, Fahrleitner-Pammer A, März W, Tomaschitz A, Pilz S.

Diabetes Obes Metab. 2016 Oct;18(10):1006-12. doi: 10.1111/dom.12709. Epub 2016 Jul 28.

PMID:
27334070
33.

Dietary Salt Intake Is a Determinant of Cardiac Changes After Treatment of Primary Aldosteronism: A Prospective Study.

Catena C, Colussi G, Novello M, Verheyen ND, Bertin N, Pilz S, Tomaschitz A, Sechi LA.

Hypertension. 2016 Jul;68(1):204-12. doi: 10.1161/HYPERTENSIONAHA.116.07615. Epub 2016 May 31.

PMID:
27245179
34.

Vitamin D and cardiovascular disease prevention.

Pilz S, Verheyen N, Grübler MR, Tomaschitz A, März W.

Nat Rev Cardiol. 2016 Jul;13(7):404-17. doi: 10.1038/nrcardio.2016.73. Epub 2016 May 6. Review.

PMID:
27150190
35.

Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial.

Grübler MR, Gaksch M, Kienreich K, Verheyen N, Schmid J, Ó Hartaigh BW, Richtig G, Scharnagl H, Meinitzer A, Pieske B, Fahrleitner-Pammer A, März W, Tomaschitz A, Pilz S.

J Clin Hypertens (Greenwich). 2016 Jul;18(7):608-13. doi: 10.1111/jch.12825. Epub 2016 Apr 21.

36.

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trial.

Tomaschitz A, Verheyen N, Meinitzer A, Pieske B, Belyavskiy E, Brussee H, Haas J, März W, Pieske-Kraigher E, Verheyen S, Ofner-Ziegenfuss L, Hartaigh BÓ, Schwetz V, Aberer F, Grübler M, Lang F, Alesutan I, Voelkl J, Gaksch M, Horina JH, Dimai HP, Rus-Machan J, Stiegler C, Ritz E, Fahrleitner-Pammer A, Pilz S.

J Hypertens. 2016 Jul;34(7):1347-56. doi: 10.1097/HJH.0000000000000927.

PMID:
27065001
37.

Vitamin D Supplementation and Hemoglobin Levels in Hypertensive Patients: A Randomized Controlled Trial.

Ernst JB, Tomaschitz A, Grübler MR, Gaksch M, Kienreich K, Verheyen N, März W, Pilz S, Zittermann A.

Int J Endocrinol. 2016;2016:6836402. doi: 10.1155/2016/6836402. Epub 2016 Feb 23.

38.

Vitamin D and Mortality.

Pilz S, Grübler M, Gaksch M, Schwetz V, Trummer C, Hartaigh BÓ, Verheyen N, Tomaschitz A, März W.

Anticancer Res. 2016 Mar;36(3):1379-87. Review.

PMID:
26977039
39.

Aldosterone-to-Renin Ratio Is Associated With Reduced 24-Hour Heart Rate Variability and QTc Prolongation in Hypertensive Patients.

Grübler MR, Kienreich K, Gaksch M, Verheyen N, Hartaigh BÓ, Fahrleitner-Pammer A, März W, Schmid J, Oberreither EM, Wetzel J, Catena C, Sechi LA, Pieske B, Tomaschitz A, Pilz S.

Medicine (Baltimore). 2016 Feb;95(8):e2794. doi: 10.1097/MD.0000000000002794.

40.

Strain Analysis by Tissue Doppler Imaging: Comparison of Conventional Manual Measurement with a Semiautomated Approach.

Schmid J, Kaufmann R, Grübler MR, Verheyen N, Weidemann F, Binder JS.

Echocardiography. 2016 Mar;33(3):372-8. doi: 10.1111/echo.13100. Epub 2015 Oct 30.

PMID:
26515731
41.

Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study.

Verheyen ND, Kienreich K, Gaksch M, van Ballegooijen AJ, Grübler MR, Hartaigh BÓ, Schmid J, Fahrleitner-Pammer A, Kraigher-Krainer E, Colantonio C, Belyavskiy E, Treiber G, Catena C, Brussee H, Pieske B, März W, Tomaschitz A, Pilz S.

J Clin Hypertens (Greenwich). 2016 Jun;18(6):543-50. doi: 10.1111/jch.12710. Epub 2015 Oct 12.

42.

Randomized Evaluation of Glycemic Control in the Medical Intensive Care Unit Using Real-Time Continuous Glucose Monitoring (REGIMEN Trial).

De Block CE, Gios J, Verheyen N, Manuel-y-Keenoy B, Rogiers P, Jorens PG, Scuffi C, Van Gaal LF.

Diabetes Technol Ther. 2015 Dec;17(12):889-98. doi: 10.1089/dia.2015.0151. Epub 2015 Aug 25.

PMID:
26305390
43.

Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients.

Catena C, Colussi G, Frangipane A, Russo A, Verheyen ND, Sechi LA.

Nutr Metab Cardiovasc Dis. 2015 Oct;25(10):968-74. doi: 10.1016/j.numecd.2015.06.009. Epub 2015 Jul 3.

PMID:
26234565
44.

Association of Post-Saline Load Plasma Aldosterone Levels With Left Ventricular Hypertrophy in Primary Hypertension.

Catena C, Verheyen ND, Url-Michitsch M, Kraigher-Krainer E, Colussi G, Pilz S, Tomaschitz A, Pieske B, Sechi LA.

Am J Hypertens. 2016 Mar;29(3):303-10. doi: 10.1093/ajh/hpv104. Epub 2015 Jul 10.

PMID:
26163660
45.

Homoarginine in the renal and cardiovascular systems.

Pilz S, Meinitzer A, Gaksch M, Grübler M, Verheyen N, Drechsler C, Hartaigh BÓ, Lang F, Alesutan I, Voelkl J, März W, Tomaschitz A.

Amino Acids. 2015 Sep;47(9):1703-13. doi: 10.1007/s00726-015-1993-2. Epub 2015 May 1. Review.

PMID:
25929587
46.

Plasma aldosterone and left ventricular diastolic function in treatment-naïve patients with hypertension: tissue-Doppler imaging study.

Catena C, Verheyen N, Pilz S, Kraigher-Krainer E, Tomaschitz A, Sechi LA, Pieske B.

Hypertension. 2015 Jun;65(6):1231-7. doi: 10.1161/HYPERTENSIONAHA.115.05285. Epub 2015 Mar 23.

PMID:
25801873
47.

Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.

Pilz S, Gaksch M, Kienreich K, Grübler M, Verheyen N, Fahrleitner-Pammer A, Treiber G, Drechsler C, Ó Hartaigh B, Obermayer-Pietsch B, Schwetz V, Aberer F, Mader J, Scharnagl H, Meinitzer A, Lerchbaum E, Dekker JM, Zittermann A, März W, Tomaschitz A.

Hypertension. 2015 Jun;65(6):1195-201. doi: 10.1161/HYPERTENSIONAHA.115.05319. Epub 2015 Mar 23.

PMID:
25801871
48.

Homoarginine in patients with primary hyperparathyroidism.

Tomaschitz A, Verheyen N, Gaksch M, Meinitzer A, Pieske B, Kraigher-Krainer E, Colantonio C, März W, Schmidt A, Belyavskiy E, Rus-Machan J, van Ballegooijen AJ, Stiegler C, Amrein K, Ritz E, Fahrleitner-Pammer A, Pilz S.

Am J Med Sci. 2015 Apr;349(4):306-11. doi: 10.1097/MAJ.0000000000000419.

PMID:
25647833
49.

Associations of daytime, nighttime, and 24-hour heart rate with four distinct markers of inflammation in hypertensive patients: the Styrian Hypertension Study.

O Hartaigh B, Gaksch M, Kienreich K, Grübler MR, Verheyen N, März W, Tomaschitz A, Gill TM, Pilz S.

J Clin Hypertens (Greenwich). 2014 Dec;16(12):856-61. doi: 10.1111/jch.12420. Epub 2014 Sep 30.

50.

Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications.

Tomaschitz A, Piecha G, Ritz E, Meinitzer A, Haas J, Pieske B, Wiecek A, Rus-Machan J, Toplak H, März W, Verheyen N, Gaksch M, Amrein K, Kraigher-Krainer E, Fahrleitner-Pammer A, Pilz S.

Clin Exp Hypertens. 2015;37(2):108-15. doi: 10.3109/10641963.2014.913604. Epub 2014 Apr 30.

PMID:
24785704

Supplemental Content

Loading ...
Support Center